HLA-B*35: 05 is a protective allele with a unique structure among HIV-1 CRF01-AE-infected Thais, in whom the B*57 frequency is low
Mori M., Wichukchinda N., Miyahara R., Rojanawiwat A., Pathipvanich P., Maekawa T., Miura T., Goulder P., Yasunami M., Ariyoshi K., Sawanpanyalert P.
Objective: To identify protective human leukocyte antigen (HLA) alleles in an HIVinfected south-east Asian population, in whom HLA-B57 prevalence is lower than other ethnic groups, and HIV-1 CRF01-AE is the dominant circulating subtype. Design: Cross-sectional study of Thai patients with chronic HIV infection. Methods: Five hundred and fifty-seven HIV-1 CRF01-AE-infected Thais were recruited. Their HLA type and viral load were determined to statistically analyze the association of each allele in viral control. In-silico molecular dynamics was also used to evaluate the effect of HLA structure variants on epitope binding. Results: HLA-B35:05 was identified as the most protective allele (P=0.003, q=0.17), along with HLA-B57:01 (P=0.044, q=0.31). Structurally, HLA-B35:05 belonged to the HLA-B35-PY group of HLA-B35 alleles; however, unlike the other HLA-B35 alleles that carry Arg (R) at residue 97, it has unique sequences at T94, L95, and S97, located within the peptide-binding groove. Analysis of the three-dimensional HLA structure and molecular dynamics indicates that S97 in HLA-B35:05 leads to less flexibility in the groove, and shorter distances between the a-helixes compared with the disease-susceptible HLA-B35-PY allele, HLA-B35:01. Conclusion: These data indicate the existence of a protective effect of HLA-B57 across ethnic groups and highlight HLA-B35:05 as an allele uniquely protective in subtype CRF01-AE-infected Thais. The divergence of HLA-B35:05 from conventional HLA-B35-PY structural sequences at the peptide-binding groove is consistent with previous studies that have identified HLA residue 97 as strongly influential in shaping HLA impact on immune control of HIV, and that a more restricted peptide-binding motif may be associated with improved control. © 2014 Wolters Kluwer Health.